Bionano Genomics Affirms FY2025 Sales Guidance of $26.000M-$30.000M vs $29.363M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 million vs $29.363 million estimate.
Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 million vs $29.363 million estimate.